1. Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis.
- Author
-
Cavalcanti de Queiroz A, Alves MA, Barreiro EJ, Lima LM, and Alexandre-Moreira MS
- Subjects
- Analysis of Variance, Animals, Antiprotozoal Agents chemistry, Antiprotozoal Agents pharmacology, Caspases analysis, Cell Cycle, Cell Line, Cell Membrane metabolism, Cell Membrane Permeability, Female, Flow Cytometry, Inhibitory Concentration 50, Macrophages parasitology, Membrane Potential, Mitochondrial, Mice, Mice, Inbred BALB C, Pentamidine chemistry, Pentamidine pharmacology, Pentamidine therapeutic use, Phospholipids metabolism, Phosphorylcholine analogs & derivatives, Phosphorylcholine chemistry, Phosphorylcholine pharmacology, Phosphorylcholine therapeutic use, Semicarbazones chemistry, Semicarbazones pharmacology, Antiprotozoal Agents therapeutic use, Leishmania mexicana drug effects, Leishmaniasis, Cutaneous drug therapy, Semicarbazones therapeutic use
- Abstract
In the present study, we investigated the in vitro and in vivo leishmanicidal activity of synthetic compounds, containing a semicarbazone scaffold as a peptide mimetic framework. The leishmanicidal effect against amastigotes of Leishmania amazonensis was also evaluated at concentration of 100 μM-0.01 nM. The derivatives 2e, 2f, 2g and 1g, beyond the standards miltefosine and pentamidine, significantly diminished the number of L. amazonensis amastigotes in macrophages. These derivatives were also active against amastigotes of L. braziliensis. As 2g presented potent leishmanicidal activity against the amastigotes of L. amazonensis in macrophages, we also investigated the in vivo leishmanicidal activity of this compound against L. amazonensis. Approximately 10
5 L. amazonensis promastigotes were subcutaneously inoculated into the dermis of the right ear of BALB/c mice, which were subsequently treated with 2g (p.o. or i.p.), miltefosine (p.o.) or glucantime (i.p.) at 30 μmol/kg/day x 28 days. Thus, a similar reduction in the lesion size was observed after the administration of 2g through oral (63.7 ± 10.1%) and intraperitoneal (61.8 ± 3.7%) routes. A larger effect was observed after treatment with miltefosine (97.7 ± 0.4%), and glucantime did not exhibit activity at the dose administered. With respect to the ear parasite load, 2g diminished the number of parasites by p.o. (30.5 ± 5.1%) and i.p. (33.3 ± 4.3%) administration. In addition, 2g induced in vitro apoptosis, autophagy and cell cycle alterations on L. amazonensis promastigotes. In summary, the derivative 2g might represent a lead candidate for antileishmanial drugs, as this compound displayed pronounced leishmanicidal activity., (Copyright © 2019 Elsevier Inc. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF